Overview Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia (PART 2) Status: Completed Trial end date: 2017-07-31 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the Efficacy and Safety of DWJ1252 in treatment of Functional Dyspepsia. Phase: Phase 3 Details Lead Sponsor: Daewoong Pharmaceutical Co. LTD.